This site does not have SSL enabled. Please visit http://ir.amarantus.com/news/detail/2107/manf-therapeutics-receives-notice-of-allowance-from-us-patent-trademark-office-covering-the-use-of-manf-or-cdnf-as-a-treatment-for-glaucoma-macular-degeneration-and-retinitis-pigmentosa.